Crossmark

Peripheral apoE4 enhances Alzheimer’s pathology and impairs cognition by compromising cerebrovascular function

Crossref DOI link: https://doi.org/10.1038/s41593-022-01127-0

Published Online: 2022-08-01

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Chia-Chen https://orcid.org/0000-0001-7203-3926
Zhao, Jing https://orcid.org/0000-0002-4520-6307
Fu, Yuan

Inoue, Yasuteru

Ren, Yingxue

Chen, Yuanxin

Doss, Sydney V.

Shue, Francis https://orcid.org/0000-0003-1659-1952
Jeevaratnam, Suren

Bastea, Ligia

Wang, Na

Martens, Yuka A. https://orcid.org/0000-0002-5194-4269
Qiao, Wenhui

Wang, Minghui https://orcid.org/0000-0001-9171-4962
Zhao, Na https://orcid.org/0000-0001-8648-9422
Jia, Lin

Yamazaki, Yu https://orcid.org/0000-0002-0806-4960
Yamazaki, Akari

Rosenberg, Cassandra L.

Wang, Zhen

Kong, Dehui

Li, Zonghua https://orcid.org/0000-0001-5242-9608
Kuchenbecker, Lindsey A.

Trottier, Zachary A.

Felton, Lindsey

Rogers, Justin

Quicksall, Zachary S.

Linares, Cynthia

Knight, Joshua

Chen, Yixing

Kurti, Aishe

Kanekiyo, Takahisa https://orcid.org/0000-0001-6751-9374
Fryer, John D. https://orcid.org/0000-0003-3390-2994
Asmann, Yan W.

Storz, Peter

Wang, Xusheng https://orcid.org/0000-0002-1759-9588
Peng, Junmin https://orcid.org/0000-0003-0472-7648
Zhang, Bin

Kim, Betty Y. S. https://orcid.org/0000-0001-6890-8355
Bu, Guojun https://orcid.org/0000-0003-3491-1016
License Information

Text and Data Mining valid from 2022-08-01

Version of Record valid from 2022-08-01
More Information

Article History

Received: 5 November 2020

Accepted: 22 June 2022

First Online: 1 August 2022

Competing interests

: G.B. consults for SciNeuro and Lexeo, is on the scientific advisory board for Kisbee and has consulted for AbbVie, E-Scape, Eisai and Vida Ventures. All other authors declare no competing interests.

Document is current

Any future updates will be listed below